Previous Article | Next Article ![]()
Journal of Bacteriology, December 2008, p. 8197-8203, Vol. 190, No. 24
0021-9193/08/$08.00+0 doi:10.1128/JB.01069-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Instituto de Investigaciones Biotecnológicas, Universidad Nacional de General San Martín, CONICET, San Martín 1650, Buenos Aires, Argentina,1 Instituto de Biología Molecular y Celular de Rosario and Departamento de Microbiología, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 531, S2002LRK, Rosario, Argentina,2 Comisión Nacional de Energía Atómica, División Agropecuaria, Centro Atómico Ezeiza 1804, Buenos Aires, Argentina3
Received 30 July 2008/ Accepted 1 October 2008
|
|
|---|
|
|
|---|
Members of the genus Brucella are the etiological agents of brucellosis, a worldwide-distributed zoonosis affecting both wild and domestic mammals as well as humans (14). They are facultative intracellular pathogens with the ability to invade and proliferate intracellularly in macrophages and nonprofessional phagocytes of the host, establishing long-lasting infections (5, 25). In animals, brucellosis often causes sterility in males and abortion in pregnant females, whereas in humans the disease causes undulant fever in the acute phase and severe complications in chronicity, such as endocarditis, osteoarticular complications, and neurological symptoms (11).
Once internalized, Brucella resides within a modified phagosome called the Brucella-containing vacuole (BCV), in which the bacterium survives and eventually replicates (5). The BCV undergoes a maturation process characterized by controlled and limited interaction with the endocytic pathway. Subsequently, the bacterium controls the maturation of the BCV by redirecting its traffic toward the endoplasmic reticulum (ER), where exponential intracellular replication occurs (5, 6). The VirB type IV secretion system of Brucella plays a central role in this process, probably by translocating effector proteins that modify the host's vesicular transport. In addition, several factors such as immune modulators, smooth lipopolysaccharide (LPS), and cyclic β-glucans also contribute to the virulence (1, 8, 18).
Although knowledge about the virulence factors that enable Brucella to survive inside host cells is increasing, little is known about how membrane lipid composition contributes to the interaction with the host cell. The structure and composition of the Brucella cell envelope (CE) are quite peculiar. The Brucella membrane is composed of phosphatidylethanolamine (PE), PC, ornithine lipid (OL), cardiolipin (CL), and phosphatidylglycerol (PG) (7, 9, 31). In previous work we demonstrated that in brucellae, PC synthesis occurs exclusively via the novel PC synthase pathway (Pcs) and that the endogenous methylation pathway for PC formation is not functional. Consequently, the pathogen depends on choline synthesized by the host cell to form one of its main phospholipids. The absence of PC in the CE is compensated for by increasing the amounts of the other main zwitterionic phospholipid, PE. Although the membrane level of PC does not affect some key virulence traits of Brucella such as invasion, intracellular traffic, brucellosome formation, and intracellular replication, its presence is necessary directly or indirectly to sustain a chronic infection in mice (7). In view of the importance of the membrane lipid composition for Brucella pathogenesis, in the present work we analyzed PE biosynthesis in Brucella abortus and the role it plays in membrane function and virulence by disrupting the phosphatidylserine synthase gene (pssA), whose product is responsible for the first committed step in PE synthesis.
|
|
|---|
Cloning, gene disruption, and generation of mutant strains. A DNA fragment of 847 bp containing the pssA gene of B. abortus 2308 (BAB1_0470) was amplified from genomic DNA using primers pssUP (5'-GCATAAGCCGATGGAAACGCCT-3') and pssDOWN (5'-TCAATTGTCACCGGACGAGGCT-3') and Platinum Taq DNA polymerase (Invitrogen). The amplicon was ligated into pGemTeasy (Promega Corp.) to generate the intermediate vector pGemT-pssA. This vector was subsequently digested with NarI (New England Biolabs), blunted with T4 DNA polymerase (New England Biolabs), and ligated to a Km resistance cassette from pUC4K (24) to generate the plasmid pGemT-pssA::kan. This vector was introduced into B. abortus 2308 by electroporation to obtain the corresponding knockout mutant. Double recombination events (Kmr Aps) were selected, and the corresponding gene knockout was confirmed by genomic PCR. The strain was the B. abortus pssA mutant.
To generate the pBBR4-pssA complementing plasmid, the pssA gene was excised from pGEMT-pssA by digestion with ApaI and PstI enzymes and subcloned into the pBBR4 replicative vector under control of the lac promoter. To perform the knock-in strategy, the pssA gene was excised from pGEMT-pssA by digestion with NotI and subcloned into a modified pBlueScriptKS-sacB/R vector (27). The resulting plasmid was introduced into the B. abortus pssA mutant by electroporation, and double recombination events were selected (Aps and sucrose resistance). Restoration of the pssA locus was confirmed by PCR and sequence analysis. The resulting strain was called the B. abortus pssA KI mutant.
In vivo labeling of B. abortus with [14C]acetate and quantitative analysis of lipid extracts. The lipid compositions of B. abortus 2308, the mutant, and the complemented strains were determined by labeling with sodium [14C]acetate. The strains were grown overnight in GW medium, and the cultures were washed with GW minimal medium and used to inoculate 12 ml of GW minimal medium (with or without choline) at an optical density at 600 nm (OD600) of 0.1. After the addition of 2 µCi of sodium [14C]acetate (56.50 mCi/mmol; New England Nuclear), cultures were incubated to an OD600 of 0.8. The cells were harvested by centrifugation. Lipids were extracted according to the method described previously by Bligh and Dyer (2) and separated by two-dimensional thin-layer chromatography (2D-TLC) on silica gel plates (Kieselgel 60; Merck) using chloroform-methanol-water (14:6:1) in the first phase followed by chloroform-methanol-acetic acid (13:5:2) in the second phase. After exposure to Biomax Kodak films, lipids were visualized by iodine staining. Spots corresponding to labeled lipids were scraped from the plate, and the radioactivity was quantified in a scintillation counter with 500 µl Eco-Lite scintillation liquid (ICN Biomedicals).
Growth inhibition assay. Two Whatman filter discs (6-mm diameter) containing 15 µl of 1% (vol/vol) Sarkosyl (Sigma-Aldrich Co.), 1% (wt/vol) sodium dodecyl sulfate (Invitrogen Co.), or 1% (vol/vol) Zwittergent 3-16 (Sigma-Aldrich Co.) were placed on TSA plates seeded with the different Brucella strains. Plates were incubated for at least 48 h, and the diameter of the inhibition halo was quantified.
PmB assay. The bactericidal effect of polymyxin B (PmB) was tested as follows. A total of 2.5 x 105 CFU of each strain were incubated for 60 min at 37°C with 0 (control), 10, or 30 µg ml–1 of PmB in 500 µl of 1 mM HEPES, pH 8 (Sigma-Aldrich Co.). Afterwards, serial dilutions were plated on TSA. The percent survival was calculated according to the CFU recovered from the control treatment.
Plasmid swap. To demonstrate the essentiality of either pcs or pssA, we developed a plasmid swap experiment based on the instability of two vectors from the same incompatibility group in the same bacterial population. To this end, we first generated the strain B. abortus pcs::Gm pssA::kan(pBBR4-pcs) by disrupting pssA from a pcs mutant strain bearing a plasmid expressing pcs (pBBR4-pcs) (7). The resulting strain was able to synthesize PC but not PE and was resistant to Gm, Km, and Ap. We then introduced by conjugation the plasmid pBBR1 or pBBR1-pcs (encoding resistance to Cm) into this strain. Exconjugants were selected in TSA supplemented with Gm, Km, Ap, and Cm. Three independent clones from each conjugation were selected and cultivated for 20 generations in TSA with Km, Gm, and Cm. Two hundred colonies from each clone were replica plated in TSA with Km, Gm, and Ap and in TSA with Km, Gm, and Cm, and the percentage of chasing plasmid (Aps/Cmr clones x 100) was calculated.
Cell culture infections. The HeLa and J774.A1 macrophage-like cell lines were maintained in Dulbecco modified Eagle medium and RPMI 1640, respectively, supplemented with 5% fetal bovine serum and streptomycin (50 µg ml–1)-penicillin (50 U ml–1) in a 5% CO2 atmosphere at 37°C (all of those solutions and media were purchased from Gibco). Cells (5 x 104 per well) were seeded on 24-well plates in media without antibiotics and were kept for 24 h. B. abortus infections were carried out at the indicated multiplicity of infection (MOI). After 30 or 120 min (for J774.A1 or HeLa cells, respectively) wells were washed three times with phosphate-buffered saline (PBS) and incubated for 60 min with fresh medium containing 50 µg ml–1 Gm and 100 µg ml–1 streptomycin to kill noninternalized bacteria (afterwards, antibiotics were diluted to final concentrations of 10 µg ml–1 and 20 µg ml–1, respectively). At the indicated times, infected cells were washed three times with PBS and lysed with 500 µl 0.1% Triton X-100 (Sigma-Aldrich Co.). The intracellular CFU counts were determined by plating serial dilutions on TSA with the appropriated antibiotic.
Antibodies and reagents. All the antibodies were diluted in 5% horse serum (Gibco) and 0.1% saponin (Sigma). The primary antibodies used were rabbit anti-Brucella polyclonal antibody (1:1,500), mouse immunoglobulin G anti-O-antigen monoclonal antibody (23), and mouse anti-human LAMP-1 H4A3 (Developmental Studies Hybridoma Bank, Department of Biological Sciences, University of Iowa). The secondary antibodies used were Alexa Fluor 488 goat anti-rabbit or anti-mouse and Alexa Fluor 568 goat anti-rabbit or anti-mouse (Molecular Probes, Invitrogen Co.). For DNA staining, Hoechst dye at 2 µg ml–1 (final concentration) was used.
Fluorescence microscopy. Eukaryotic cells were plated on glass coverslips and infected as described above. At the indicated times the coverslips were washed with PBS, and the cells were fixed for 15 min with 3% paraformaldehyde and then blocked for 24 h with 1% horse serum-20 mM NH4Cl solution. After immunofluorescence staining, the coverslips were mounted onto slides with FluorSave (Calbiochem). Images were made and quantitation performed in a Nikon microscope (Eclipse E600) at a magnification of x1,000, examining at least 100 cells containing bacteria from aleatory fields. Adobe Photoshop was used to merge the microscopic images taken with SPOT software (Diagnostic Instruments).
Mouse infections. Eight-week-old female BALB/c mice were intraperitoneally inoculated with 1 x 105 CFU of B. abortus strains in PBS. At 2 and 8 weeks postinfection (p.i.), spleens from infected mice were removed, weighed, and homogenized in 2 ml of PBS. Serial dilutions from individualized spleen were plated on TSA to quantify recovered CFU.
|
|
|---|
In bacteria, the first step of PE synthesis is catalyzed by phosphatidylserine synthase (PssA) (15). Analysis of the Brucella genome sequences revealed the presence of orthologs of pssA from Sinorhizobium meliloti, a gene whose product is a CDP-diacylglycerol serine O-phosphatidyltransferase responsible for PE synthesis (29).
The B. abortus 2308 gene BAB1_0470 (gi. 3788867) encodes a 278-amino-acid protein that shares 70% identity with the PssA from the related endosymbiont S. meliloti. The protein has eight putative transmembrane regions and belongs to subclass II of phosphatidylserine synthases (20).
To determine whether the product of BAB1_0470 is implicated in PE biosynthesis, an insertion mutant in the corresponding locus was generated and named the B. abortus pssA mutant. The membrane lipid compositions of B. abortus 2308 (wild type), the B. abortus pssA mutant, and the complemented B. abortus pssA(pBBR4-pssA) and B. abortus pssA KI strains, grown in a defined medium in the presence of sodium [14C]acetate, were analyzed by 2D-TLC (Fig. 1, upper panel). It was observed that disruption of pssA abrogated PE synthesis, indicating that the phospholipid is formed via synthesis of the precursor phosphatidylserine by the action of PssA. Besides the absence of the spot corresponding to PE in the B. abortus pssA mutant, no other difference was observed between the wild type and the mutant strain. Synthesis of PE in the pssA mutant was recovered by knock-in or by ectopic expression of the wild-type copy of the gene, confirming that the product of BAB1_0470 is the phosphatidylserine synthase. The absence of PE was compensated for by increasing the amounts of the other zwitterionic lipid PC (37.6% versus 29.8%), OL (28.4% versus 18.1%), and the anionic CL/PG (34% versus 20%) (Fig. 1, lower panel).
![]() View larger version (17K): [in a new window] |
FIG. 1. The B. abortus pssA mutant is not able to synthesizes PE. Total [14C]acetate-labeled lipids were extracted from GW cultures in the presence of choline and analyzed by 2D-TLC. Lipids spots corresponding to CL, PG, OL, PE, and PC are indicated. A dashed circle highlights the absence of a PE spot in the B. abortus pssA mutant. The relative percentage of lipids for each strain is represented in the graph. Data shown are means and standard deviations for triplicate samples.
|
![]() View larger version (15K): [in a new window] |
FIG. 2. The B. abortus pssA mutant needs exogenous choline for growth. B. abortus 2308 and the B. abortus pssA mutant were grown in GW, in GW with 100 µM choline (Cho), or in GW with 50 mM MgCl2. At the indicated times, aliquots were taken to measure OD600. The pssA mutant was able to growth only when choline was added.
|
Absence of PE affects the ability of Brucella abortus to sustain a productive interaction with the host cell. To assess whether the absence of PE affects some traits of Brucella virulence, such as adhesion, internalization, trafficking, and replication within both professional and nonprofessional phagocytes, a Gm protection assay was performed by infecting J774.A1 macrophages with the B. abortus pssA mutant, the wild type, or both complemented strains. As shown in Fig. 3A, the B. abortus pssA mutant showed a marked defect in intracellular survival characterized by an exponential drop of the intracellular CFU counts (3 log10 units) during the first 24 h of culture in comparison with the wild type. Afterwards, the CFU increased exponentially with growth rates comparable to that of the wild type, thus indicating that a surviving fraction of the intracellular B. abortus pssA mutant cells were able to replicate. As expected, the defect was completely reversed in both complemented strains. When a cell line with less bactericidal activity, such as HeLa, was used, a similar result was observed (Fig. 3B). Taken together, these results strongly suggests that the absence of PE does not influence intracellular growth but may affect the internalization of Brucella and/or the biogenesis of the intracellular replicative vacuole. Deficiency in the internalization of the B. abortus pssA mutant was excluded, since no differences in the distribution of bacteria per infected cell at 1 hour of infection were observed (around 50% of intracellular bacteria for both the B. abortus pssA mutant and the wild type) (data not shown).
![]() View larger version (9K): [in a new window] |
FIG. 3. The B. abortus pssA mutant has defective intracellular survival. Kinetics of intracellular survival of the wild type, the B. abortus pssA mutant, and the complemented B. abortus pssA(pBBR4-pssA) and B. abortus pssA KI strains in J774A.1 macrophage-like cells (MOI, 50:1) (A) and HeLa cells (MOI, 500:1) (B) are shown. Intracellular bacterial CFU numbers were determined after lysis of infected cells as described in Materials and Methods. In both professional and nonprofessional phagocytic cells, the absence of PE severely affected the survival during the first 24 h p.i. Each determination was performed in duplicate, and values are the means ± standard deviations from three independent experiments.
|
![]() View larger version (23K): [in a new window] |
FIG. 4. The absence of PE impairs trafficking in the host cell. (A to D) Representative epifluorescence micrographs of infected HeLa cells at 6 and 24 h p.i. (panels A/C and B/D, respectively). Infections were done with the wild type (A and B) or the pssA mutant strain (C and D), and HeLa cells were labeled for LAMP-1 (red) or Brucella (green) as described in Materials and Methods. Arrowheads indicate the bacterium and the surrounding area which is magnified (x3) in the insets. (E) Quantification of the LAMP-1 marker acquired by BCVs. Immunofluorescence stains of HeLa infections were made as described in Materials and Methods. The percentage (mean ± standard deviation) of LAMP-1-positive BCVs is indicated for the wild type and the pssA mutant strain. ***, P < 0.001, Mann-Whitney test.
|
Figure 5 shows the recovered CFU per spleen at 2 and 8 weeks p.i. The B. abortus pssA mutant was significantly attenuated in comparison to the wild type or the complemented strain (P = 0.0159 at 2 weeks p.i.; P = 0.0286 at 8 weeks p.i.), showing 10-fold-lower spleen CFU counts. The colonization defect of the B. abortus pssA mutant was concomitant with reduced splenomegaly, a hallmark of Brucella infection (data not shown). These results indicate that Brucella requires PE to achieve an efficient infection in the mammal host.
![]() View larger version (8K): [in a new window] |
FIG. 5. The B. abortus pssA mutant is defective for spleen colonization. BALB/c mice were inoculated intraperitoneally with the wild type, the pssA mutant, or the complemented knock-in (KI) strain as indicated in Materials and Methods. Individual spleen CFU values were plotted, and the horizontal bars represent the median CFU for each treatment group. *, P < 0.05 (compared to the group that received the wild-type strain), Kruskal-Wallis test.
|
|
|
|---|
The B. abortus pssA mutant showed altered envelope properties characterized by high sensitivity to the disrupting action of anionic detergents as well as elevated resistance to zwitterionic ones. Notably, the mutant was very sensitive to polycationic peptides, and this defect was not related to major changes in the structure of the LPS. However, we cannot rule out minor changes in LPS structure that could be relevant for PmB resistance. All these observations strongly suggest that the absence of PE is responsible for CE perturbations associated with the effects of detergents and membrane-disrupting peptides.
Although it is not required for vegetative growth, PE is critical for Brucella virulence. The B. abortus pssA mutant is defective in promoting the maturation of the replicative BCV, as illustrated by the presence of the late endosomal/lysosomal LAMP-1 marker decorating more than 50% of the BCV at 24 h p.i. (Fig. 4). This defect explains the deficient intracellular performance of the mutant in both professional and nonprofessional phagocytes (Fig. 3). The B. abortus pssA mutant was attenuated in the mouse model of infection, probably as a consequence of the high sensitivity to polycationic peptides and the traffic defects (Fig. 5). These findings, and our previous report showing that Brucella needs PC for full virulence (7), support the concept that membrane lipid composition plays an important role in the Brucella-host cell interaction. A likely explanation is that the lipid composition influences the structure or function of certain bacterial surface protein complexes needed to survive inside the cell. There are several reports describing how lipid composition influences the function or assembly of multiprotein complexes such as flagellum or secretion systems. In E. coli, PE is essential for the function of the electron transfer chain (21), for motility and chemotaxis (26), and for assembly and function of the lactose permease (3, 4). A PC-defective mutant of Agrobacterium tumefaciens has a loss of virulence due to reduced transcription of the VirB apparatus (33). In Legionella pneumophila, a mutant unable to form PC is avirulent, and this defect could be attributed to the loss of flagellin (10).
The major virulence factor of Brucella is the type IV secretion system encoded by the virB operon, which is essential for the maturation of the BCV and the establishment of an ER-derived vacuole where bacterial replication occurs (6, 28, 30). It was postulated that the Brucella VirB system delivers effectors to the host cell in order to control the fate of the BCV, but the nature of the putative effector(s) has not yet been identified. Given the reduced efficiency of the B. abortus pssA mutant in avoiding degradation in phagolysosomes and the establishment of the intracellular replicative vacuole, it is tempting to speculate that the membrane lipid composition could affect the assembly or function of the VirB machinery. To date, the lack of a model system to check the function of the Brucella VirB system precludes us from directly testing whether a link between the membrane lipid composition and the VirB apparatus exists. Independently of the molecular mechanism involved, the altered membrane properties, the defects in intracellular traffic, and the attenuated virulence in mice clearly indicate that the membrane lipid composition is critical for the virulence of Brucella. Further work is required to understand how phospholipids influence the Brucella-host cell interaction.
Published ahead of print on 17 October 2008. ![]()
|
|
|---|
3)-beta-D-glucan (curdlan). J. Bacteriol. 184:4114-4123.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»